Pirtobrutinib,Venetoclax,Rituximab
Eli Lilly,Roche,Abbvie
['pirto']
jennifer brown, md, phd, discusses genomic evolution of pirtobrutinib resistance in frankfurt at the 2023 eha congress #eha2023 
Translating Hematologic Oncology Discoveries into Practice.